col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

215 Results       Page 1

Wiley: British Journal of Haematology
  original article Date Title Authors   All Authors
1 [GO] 2022―May―17 Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers Eleonora Petito, Elisabetta Colonna, Emanuela Falcinelli, Anna Maria Mezzasoma, Enrica Cesari, Elisa Giglio, et al. (+4)
2 [GO] 2022―May―10 Antibody responses to SARS-CoV -2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapies W. Y. Chan, C. Zhu, E. Sanchez, R. Gupta, A. K. Fielding, A. Khwaja, et al. (+2)
3 [GO] 2022―Apr―12 Can B cell-deficient patients rely on COVID-19 vaccine-induced T cell immunity? Tanaya Shree
4 [GO] 2022―Mar―14 Immune response and adverse events after vaccination against SARS-CoV -2 in adult patients with transfusion-dependent thalassaemia Polyxeni Delaporta, Evangelos Terpos, Elena E. Solomou, Sentiljana Gumeni, Evangelia Nitsa, Filia Apostolakou, et al. (+6)
5 [GO] 2022―Mar―09 Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in patients with haematological diseases treated with anti-CD20 antibodies: An observational study Masashi Nishikubo, Yoshimitsu Shimomura, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, et al. (+15)
6 [GO] 2022―Mar―07 Rituximab-treated lymphoma patients develop strong CD8 T-cell responses following COVID-19 vaccination Jon Riise, Saskia Meyer, Isaac Blaas, Adity Chopra, Trung T Tran, Marina Delic-Sarac, et al. (+16)
7 [GO] 2022―Feb―28 Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, et al. (+5)
8 [GO] 2022―Feb―17 Depletion of CD38 -positive regulatory T cells by anti-CD38 monoclonal antibodies induces a durable response to SARS-CoV -2 vaccination in patients with plasma cell dyscrasia Toshiki Terao, Takashi Naduka, Daisuke Ikeda, Ami Fukumoto, Yuya Kamura, Ayumi Kuzume, et al. (+6)
9 [GO] 2022―Feb―17 Serological response to SARS-CoV-2 mRNA-LNP vaccine in patients with multiple myeloma: a negative impact of CD38 + Treg? Frédéric Baron, Jo Caers, Stéphanie Humblet-Baron
10 [GO] 2022―Feb―12 The Impact of B-cell Directed Therapy on SARS-CoV-2 Vaccine Efficacy in CLL Chaitra Ujjani, Mazyar Shadman, Ryan C. Lynch, Brian Tu, Philip A. Stevenson, Caitlin Grainger, et al. (+14)
11 [GO] 2022―Feb―02 Association of Rhesus Factor Blood Type with Risk of SARS-CoV-2 Infection and COVID-19 Severity Jeffrey L Anderson, Heidi T. May, Stacey Knight, Tami L Bair, Benjamin D Horne, Kirk U Knowlton
12 [GO] 2022―Jan―25 Platelets modulate CD4 + T Cell function in Covid-19 Through A PD-L1 Dependent Mechanism Ana Paletta, Facundo Di Diego García, Augusto Varese, Fernando Erra Diaz, Julián García, Juan Carlos Cisneros, et al. (+12)
13 [GO] 2022―Jan―25 BNT162b2 mRNA COVID-19 vaccine booster induces seroconversion in patients with B-cell non-Hodgkin lymphoma who failed to respond to two prior vaccine doses Irit Avivi, Efrat Luttwak, Esther Saiag, Tami Halperin, Shira Haberman, Ariel Sarig, et al. (+4)
14 [GO] 2022―Jan―25 Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titers O. Šušol, B. Hájková, H. Zelená, R. Hájek
15 [GO] 2022―Jan―22 Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T cell response Karthik Ramasamy, Ross Sadler, Sally Jeans, Paul Weeden, Sherin Varghese, Alison Turner, et al. (+14)
16 [GO] 2022―Jan―14 The impact of COVID-19 vaccination on patients with a history of heparin induced thrombocytopenia U. Faruqi, K. White, N. Murray, J. Cutler, K. Breen
17 [GO] 2022―Jan―14 COVID-19 Vaccine Response in Chronic Lymphocytic Leukaemia is More Than Just Seroconversion Clare Sun
18 [GO] 2022―Jan―14 Response to vaccination against SARS-CoV-2 in 168 patients with Waldenström macroglobulinemia: a French Innovative Leukemia Organization (FILO) study Cécile Tomowiak, Véronique Leblond, Kamel Laribi, Marine Baron, Christian Puppinck, Paulette Gérard, et al. (+7)
19 [GO] 2021―Dec―28 Plasma microparticles of intubated COVID-19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine-dependent manner Yohann Garnier, Livia Claude, Patricia Hermand, Evely Sachou, Aurélie Claes, Kassandra Desplan, et al. (+7)
20 [GO] 2021―Dec―28 COVID-19 Vaccine Failure in Chronic Lymphocytic Leukaemia and Monoclonal B-Lymphocytosis; Humoral and Cellular Immunity Yandong Shen, Jane A. Freeman, Juliette Holland, Ann Solterbeck, Kartik Naidu, Asha Soosapilla, et al. (+12)
21 [GO] 2021―Dec―28 Post-COVID-19 syndrome in patients with haematological disorders who have survived infection with severe acute respiratory syndrome coronavirus-2 John Willan, Lidice Hernandez, Harley Katz, Nicola Gray, Nicola Bienz
22 [GO] 2021―Dec―10 Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia Mahmoud I. Elbadry, Ahmed Tawfeek, Mohammed G. Abdellatif, Eman H. Salama, Ahmed Abudeif, Hany Mahmoud, et al. (+3)
23 [GO] 2021―Dec―07 Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response Patrick Reimann, Hanno Ulmer, Beatrix Mutschlechner, Magdalena Benda, Luciano Severgnini, Andreas Volgger, et al. (+10)
24 [GO] 2021―Dec―01 Effectiveness of COVID-19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting? Salyka Sengsayadeth, Larisa Broglie, Bipin N. Savani
25 [GO] 2021―Nov―16 A case of severe aplastic anaemia after SARS-CoV-2 vaccination Nicola Cecchi, Juri Alessandro Giannotta, Wilma Barcellini, Bruno Fattizzo
26 [GO] 2021―Nov―12 Adjunctive viral cell culture supports treatment decision-making in patients with secondary humoral immunodeficiency and persistent SARS-CoV-2 infection Scott J. C. Pallett, Rachel Wake, Jonathan Youngs, Cassie Pope, Ngee Keong Tan, Joshua Taylor, et al. (+10)
27 [GO] 2021―Nov―11 Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy Stephen Booth, Helen M. Curley, Csilla Varnai, Roland Arnold, Lennard Y. W. Lee, Naomi A. Campton, et al. (+29)
28 [GO] 2021―Oct―29 Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Vladislav Litachevsky, Itzchak Levy, Liraz Olmer, et al. (+5)
29 [GO] 2021―Oct―28 Is COVID-19 less severe in CML patients than in those with other haematological cancers? Simone Claudiani
30 [GO] 2021―Oct―19 T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies Vincenzo Marasco, Cristiana Carniti, Anna Guidetti, Lucia Farina, Martina Magni, Rosalba Miceli, et al. (+9)
31 [GO] 2021―Oct―15 COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report Massimo Breccia, Elisabetta Abruzzese, Vincenzo Accurso, Immacolata Attolico, Sara Barulli, Micaela Bergamaschi, et al. (+43)
32 [GO] 2021―Oct―13 Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina J. Chavda, et al. (+16)
33 [GO] 2021―Oct―09 Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study Deepa J. Arachchillage, Indika Rajakaruna, Ian Scott, Mihaela Gaspar, Zain Odho, Winston Banya, et al. (+11)
34 [GO] 2021―Oct―09 Conflicting impacts of tocilizumab and colchicine in COVID-19-associated coagulop Suhair Abdeen, Rami Abu-Fanne, Khalil Bdeir, Emad Maraga, Mohamed Higazi, Douglas B. Cines, et al. (+2)
35 [GO] 2021―Sep―21 Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies Thomas A. Fox, Amy A. Kirkwood, Louise Enfield, Maeve O'Reilly, Suzanne Arulogun, Shirley D'Sa, et al. (+14)
36 [GO] 2021―Sep―16 Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine Maria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, et al. (+9)
37 [GO] 2021―Sep―15 Refusing blood transfusions from COVID-19-vaccinated donors: are we repeating history? Jeremy W. Jacobs, Lorin A. Bibb, Bipin N. Savani, Garrett S. Booth
38 [GO] 2021―Sep―14 The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey Rhys Hall, John Meenan, Diana Mihalca, Alvin Katumba, Saket Badle, Dede-Kossi Osakonor, et al. (+6)
39 [GO] 2021―Sep―09 Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study Deepa J. Arachchillage, Indika Rajakaruna, Zain Odho, Christina Crossette-Thambiah, Phillip L. R. Nicolson, Lara N. Roberts, et al. (+24)
40 [GO] 2021―Aug―30 Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response Carla Schenker, Cédric Hirzel, Laura N. Walti, Sacha S. Zeerleder, Martin Andres, Alban Ramette, et al. (+4)
41 [GO] 2021―Aug―27 A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK Alexandros Rampotas, Edmund Watson, Kieran Burton, Quentin A. Hill, Sue Pavord
42 [GO] 2021―Aug―04 Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients Magdalena Benda, Beatrix Mutschlechner, Hanno Ulmer, Claudia Grabher, Luciano Severgnini, Andreas Volgger, et al. (+9)
43 [GO] 2021―Aug―02 Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia Paul Saultier, Laetitia Ninove, Sarah Szepetowski, Mathilde Veneziano, Sandrine Visentin, Vincent Barlogis, et al. (+5)
44 [GO] 2021―Jul―29 Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy Wei Yee Chan, Emilie Sanchez, Selina J. Chavda, Catherine S. Y. Lecat, Louise Ainley, Ke Xu, et al. (+11)
45 [GO] 2021―Jul―27 Haemophagocytosis and atypical vacuolated lymphocytes in bone marrow and blood films after SARS-CoV-2 vaccination Mouna Sassi, Linda Khefacha, Rihem Merzigui, Rim Rakez, Sarra Boukhriss, Mohamed A. Laatiri
46 [GO] 2021―Jul―17 COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies Francesco Passamonti, Alessandra Romano, Marco Salvini, Francesco Merli, Matteo G. Della Porta, Riccardo Bruna, et al. (+48)
47 [GO] 2021―Jul―11 Immature platelets in COVID-19 infection Robert W. Maitta
48 [GO] 2021―Jul―06 Experts’ views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease Uri Hamiel, Alina Kurolap, Ian J. Cohen, Noa Ruhrman-Shahar, Tova Hershkovitz, Claus Niederau, et al. (+5)
49 [GO] 2021―Jun―27 Cold agglutinin disease after COVID-19 vaccine Shaima Al Aoun, Ibraheem Motabi
50 [GO] 2021―Jun―25 Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine Valerio De Stefano, Marcello Candelli, Elena Rossi, Francesco Franceschi
51 [GO] 2021―Jun―16 The clinical course of COVID-19 in pregnant versus non-pregnant women requiring hospitalisation: results from the multicentre UK CA-COVID-19 study Christina Crossette-Thambiah, Pip Nicholson, Indika Rajakaruna, Alexander Langridge, Zara Sayar, Maria Rita Perelta, et al. (+10)
52 [GO] 2021―Jun―16 Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients Daniel Welder, Haekyung Jeon-Slaughter, Bilal Ashraf, Sung-Hee Choi, Weina Chen, Ibrahim Ibrahim, Taha Bat
53 [GO] 2021―Jun―16 Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms Onima Chowdhury, Hannah Bruguier, Garry Mallett, Nikolaos Sousos, Kirsty Crozier, Caroline Allman, et al. (+10)
54 [GO] 2021―Jun―16 Primary Haemophagocytic Lymphohistiocytosis (Chédiak-Higashi Syndrome) triggered by acute SARS-CoV-2 infection in a 6-week-old infant M Lange, T Linden, HL Müller, AM Flasskuehler, H Koester, K Lehmberg, et al. (+4)
55 [GO] 2021―Jun―11 COVID-19 and Immunothrombosis: emerging understanding and clinical management Rebecca J. Shaw, Charlotte Bradbury, Simon T. Abrams, Guozheng Wang, Cheng-Hock Toh
56 [GO] 2021―Jun―11 Immunothrombosis: a COVID-19 concerto George Goshua, Ayesha Butt, Alfred I. Lee
57 [GO] 2021―Jun―11 Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine Quentin Scanvion, Marc Lambert, Eric Hachulla, Louis Terriou
58 [GO] 2021―Jun―09 Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts Conor McCafferty, Suelyn Van Den Helm, Natasha Letunica, Chantal Attard, Vasiliki Karlaftis, Tengyi Cai, et al. (+10)
59 [GO] 2021―Jun―08 Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19 Pratik A. Patel, Stacey A. Lapp, Gabrielle Grubbs, Venkata V. Edara, Christina A. Rostad, Claire L. Stokes, et al. (+6)
60 [GO] 2021―Jun―07 Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT) Sandheeah Ramdeny, Ailidh Lang, Sara Al-Izzi, Alexander Hung, Imran Anwar, Poornima Kumar
61 [GO] 2021―Jun―07 Rectus sheath and retroperitoneal haematomas in patients with Coronavirus 2019 infection Phoebe Hazenberg, Symeon Lechareas, Marcelo Vasquez Rios, Miriam Taegtmeyer, Richard McWilliams, Tina Dutt
62 [GO] 2021―Jun―04 Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia Patrick Harrington, Katie J. Doores, Deepti Radia, Amy O’Reilly, Ho Pui Jeff Lam, Jeffrey Seow, et al. (+15)
63 [GO] 2021―Jun―02 Exacerbation of immune thrombocytopenia following Covid-19 vaccination David J. Kuter
64 [GO] 2021―May―30 Alpha-defensins: risk factor for thrombosis in COVID-19 infection Suhair Abdeen, Khalil Bdeir, Rami Abu-Fanne, Emad Maraga, Mohamed Higazi, Nigar Khurram, et al. (+7)
65 [GO] 2021―May―30 Antithrombin III deficiency-induced coagulopathy in the context of COVID-19: a case series Andrew J. Gardner, Daniel J. Kirkin, Sancho Rodriguez-Villar, Gonzalo Leoz Abellanas, Alice Tee, Antonio Valentin
66 [GO] 2021―May―26 COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey Wilma Barcellini, Bruno Fattizzo, Juri A. Giannotta, Luisa Quattrocchi, Semra Aydin, Federica Barone, et al. (+9)
67 [GO] 2021―May―26 Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned Vania Munaretto, Vincenzo Voi, Giovanni Palazzi, Lucia Dora Notarangelo, Paola Corti, Valentina Baretta, et al. (+26)
68 [GO] 2021―May―24 Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis Birgitte Tholin, Waleed Ghanima, Gunnar Einvik, Bernt Aarli, Eivind Brønstad, Ole H. Skjønsberg, Knut Stavem
69 [GO] 2021―May―16 Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19 Gina Sangha, Kunaal Kaushik, Amelia Robinson, Thomas Ainge, Moez Dungarwalla, Arup Chakraborty
70 [GO] 2021―May―16 Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response Henry Wood, Austin G. Kulasekararaj
71 [GO] 2021―May―15 Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain María E. Mingot-Castellano, Patricia Alcalde-Mellado, Cristina Pascual-Izquierdo, Gloria Perez Rus, Aida Calo Pérez, María P. Martinez, et al. (+9)
72 [GO] 2021―May―08 Preoperative patient blood management during the SARS-CoV-2 pandemic Katie Hands, Craig Taylor, Alwyn Kotzé, Toby Richards, Shruthi Narayan
73 [GO] 2021―May―02 Immune thrombocytopenic purpura after SARS-CoV-2 vaccine Marcello Candelli, Elena Rossi, Federico Valletta, Valerio De Stefano, Francesco Franceschi
74 [GO] 2021―Apr―30 COVID-19 infection in patients with severe aplastic anaemia Casey Paton, Liza Mathews, Emma M. Groarke, Olga Rios, Jennifer Lotter, Bhavisha A. Patel, Neal S. Young
75 [GO] 2021―Apr―15 Immune thrombocytopenia during the COVID-19 pandemic Eun-Ju Lee, Xinguang Liu, Ming Hou, James B. Bussel
76 [GO] 2021―Mar―25 The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey Stephen J. Quinn, Lesley A. Anderson, Lynne Lohfeld, Charlene M. McShane
77 [GO] 2021―Mar―15 Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Patrick Harrington, Claire N. Harrison, Richard Dillon, Deepti H. Radia, Katayoun Rezvani, Kavita Raj, et al. (+8)
78 [GO] 2021―Feb―18 Unusual morphological abnormality of neutrophils in a patient with SARS-CoV-2 infection Praveen Sharma, Shano Naseem, Neelam Varma, Pankaj Malhotra
79 [GO] 2021―Feb―07 COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies Eleonora Calabretta, Jose M. Moraleda, Massimo Iacobelli, Ruben Jara, Israel Vlodavsky, Peter O’Gorman, et al. (+8)
80 [GO] 2021―Feb―03 Convalescent plasma for COVID-19 - encouraging signals of efficacy Arturo Casadevall, Aaron A. R. Tobian
81 [GO] 2021―Feb―01 Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study Alienor Xhaard, Constance Xhaard, Maud D’Aveni, Helene Salvator, Marie-Laure Chabi, Ana Berceanu, et al. (+14)
82 [GO] 2021―Jan―25 Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia Beatriz de la Cruz-Benito, María I. Rivas-Pollmar, María T. Álvarez Román, Roberto Trelles-Martínez, Monica Martín-Salces, Paula Lázaro-del Campo, et al. (+8)
83 [GO] 2021―Jan―23 Early mortality benefit with COVID-19 convalescent plasma: a matched control study Aarthi G. Shenoy, Aaron Z. Hettinger, Stephen J. Fernandez, Joseph Blumenthal, Valentina Baez
84 [GO] 2021―Jan―21 The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact Kim Orchard, Fiona L. Dignan, Julia Lee, Rachel Pearce, Monica Desai, Emma McFarlane, et al. (+3)
85 [GO] 2021―Jan―15 COVID-19-associated oxidative damage to red blood cells Muhammad Khakwani, Claire Horgan, Joanne Ewing
86 [GO] 2021―Jan―10 Impact of COVID-19 on red blood cell rheology Céline Renoux, Romain Fort, Elie Nader, Camille Boisson, Philippe Joly, Emeric Stauffer, et al. (+5)
87 [GO] 2021―Jan―06 Are mushroom-shaped erythrocytes an indicator of COVID-19? Delphine Gérard, Safa Ben Brahim, Jean François Lesesve, Julien Perrin
88 [GO] 2021―Jan―02 SARS-CoV-2-induced remission of Hodgkin lymphoma Sarah Challenor, David Tucker
89 [GO] 2020―Dec―25 von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients Maxime Delrue, Virginie Siguret, Marie Neuwirth, Bérangère Joly, Nicolas Beranger, Damien Sène, et al. (+5)
90 [GO] 2020―Dec―18 Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19 Thomas Hueso, Clémentine Bouchez, Flore Salviat, Stéphanie Foulon, Laurence Albiges, Arnaud Bayle, et al. (+6)
91 [GO] 2020―Dec―18 Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation Soracha E. Ward, Gerard F. Curley, Michelle Lavin, Helen Fogarty, Ellie Karampini, Natalie L. McEvoy, et al. (+19)
92 [GO] 2020―Dec―18 Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK) Faye A. Sharpley, Jemma Larham, Angus Haines, Faouzi Djebbari, Bing Tseu, Heather Leary, et al. (+9)
93 [GO] 2020―Dec―13 Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies Albrecht Betrains, Laurent Godinas, F. J. Sherida H. Woei-A-Jin, Wouter Rosseels, Yannick Van Herck, Natalie Lorent, et al. (+12)
94 [GO] 2020―Dec―02 COVID-19 associated Kikuchi-Fujimoto disease Laura Stimson, Richard Stitson, Maria Bahhadi-Hardo, Edward Renaudon-Smith
95 [GO] 2020―Nov―25 Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials? Keith Gomez, Mike Laffan, Charlotte Bradbury
96 [GO] 2020―Nov―22 COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial Marquita Camilleri, Jonathan Sive, William Wilson, Gavin Pang, Richard Jenner, Elizabeth Phillips, et al. (+12)
97 [GO] 2020―Nov―22 Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction Francesca Palandri, Daniela Bartoletti, Stefania Giaquinta, Federica D’Ambrosio, Giuseppe Auteri, Emanuele Sutto, et al. (+3)
98 [GO] 2020―Nov―20 SARS-CoV-2 persistence and non-protective immunity in infected haematological patients Karolina Akinosoglou, Foteini Paliogianni, Alexandros Spyridonidis, Argiris Symeonidis, Leonidas G. Alexopoulos, Dimitrios Ziazias, et al. (+3)
99 [GO] 2020―Nov―20 SARS-CoV-2 screening for asymptomatic health care workers in UK stem cell transplant units Adrian J. C. Bloor, Fiona L. Dignan, Julia Lee, Kim H. Orchard
100 [GO] 2020―Nov―05 COVID-19 in haematology patients: a multicentre West Midlands clinical outcomes analysis on behalf of the West Midlands Research Consortium Hana Morrissey, Patrick Ball, Anandadeep Mandal, Alan Nevil, Shankara Paneesha, Supratik Basu, et al. (+14)
101 [GO] 2020―Oct―26 Impact of immunosuppression on mortality in critically ill COVID-19 patients Adrien Mirouse, Michaël Darmon, Lara Zafrani, Etienne Lengliné, Elie Azoulay
102 [GO] 2020―Oct―26 Response to ‘Impact of immunosuppression on mortality in critically ill COVID-19 patients’ Thomas A. Fox, Ethan Troy-Barnes, Amy A. Kirkwood, Wei Y. Chan, James W. Day, Selina J. Chavda, et al. (+13)
103 [GO] 2020―Oct―20 Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naïve chronic lymphocytic leukaemia: a case report George Nesr, Rincy Koshy, David Foldes, Huseini Kagdi
104 [GO] 2020―Oct―10 A left shift in the oxyhaemoglobin dissociation curve in patients with severe coronavirus disease 2019 (COVID-19) Dominik J. Vogel, Federico Formenti, Andrew J. Retter, Francesco Vasques, Luigi Camporota
105 [GO] 2020―Sep―23 Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection Dina Sheha, Mohamed El-Shayeb, Yara Eid, Mariam Amin, Alia Saeed, Dina Abdou, et al. (+6)
106 [GO] 2020―Sep―18 COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience Alexandra Pike, Petra Muus, Tahla Munir, Lindsay Mitchell, Louise Arnold, Kathryn Riley, et al. (+5)
107 [GO] 2020―Aug―31 Haemoglobin oxygen affinity in patients with severe COVID-19 infection: Still unclear Gurgen Harutyunyan, Garnik Harutyunyan, Gagik Mkhoyan, Varsenik Harutyunyan, Suren Soghomonyan
108 [GO] 2020―Aug―28 COVID-19 and haemoglobin oxygen affinity: some clarity? Michael J. Shattock, Yvonne Daniel, Beverley J. Hunt, Andrew Retter, Katherine Henderson, Sarah Wilson, Claire C. Sharpe
109 [GO] 2020―Aug―07 Managing the front-line treatment for diffuse large B-cell lymphoma and high-grade B-cell lymphoma during the COVID-19 outbreak B de la Cruz-Benito, P Lázaro-del Campo, A Ramírez-López, T de Soto-Álvarez, I Sánchez-Vadillo, E García-Pérez, et al. (+6)
110 [GO] 2020―Aug―03 Abnormal concentration of porphyrins in serum from COVID-19 patients Itxaso San Juan, Chiara Bruzzone, Maider Bizkarguenaga, Ganeko Bernardo-Seisdedos, Ana Laín, Rubén Gil-Redondo, et al. (+9)
111 [GO] 2020―Aug―02 Alice in Wonderland of blood groups and COVID-19 Hisato Takagi
112 [GO] 2020―Jul―17 Clinical outcomes and risk factors for severe COVID-19 infection in patients with haematological disorders receiving chemo- or immunotherapy TA Fox, E Troy-Barnes, AA Kirkwood, WY Chan, J Day, SJ Chavda, et al. (+13)
113 [GO] 2020―Jul―17 Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients Kyung-Chan Park, Killian Donovan, Stuart Mckechnie, Narayan Ramamurthy, Paul Klenerman, Pawel Swietach
114 [GO] 2020―Jul―17 Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients Silvia Bellesi, Elisabetta Metafuni, Stefan Hohaus, Elena Maiolo, Federica Marchionni, Simone D’Innocenzo, et al. (+11)
115 [GO] 2020―Jul―17 Transfusion demand in COVID-19 patients from the Korean population: a nationwide study in South Korea John Hoon Rim, Sang Ah Lee, Chang Hoon Han, Jongha Yoo
116 [GO] 2020―Jul―17 Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series Matthieu Mahévas, Guillaume Moulis, Emmanuel Andres, Etienne Riviere, Margaux Garzaro, Etienne Crickx, et al. (+13)
117 [GO] 2020―Jul―11 Varying Presentations and Favourable Outcomes of COVID-19 Infection in Children and Young Adults with Sickle Cell Disease: An Additional Case Series with Comparisons to Published Cases Abena Appiah-Kubi, Suchitra Acharya, Carolyn Fein Levy, Adrianna Vlachos, Gholamabbas Ostovar, Kristina Murphy, et al. (+5)
118 [GO] 2020―Jul―11 Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study Paul J. Hengeveld, Aaram Omar Khader, Linda H.A. de Bruin, Inge G.P. Geelen, Eske A. van Baalen, Eva Jansen, et al. (+6)
119 [GO] 2020―Jul―11 Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection Katharine Orf, Srdan Rogosic, Daniel Dexter, Phil Ancliff, Saket Badle, Joe Brierley, et al. (+14)
120 [GO] 2020―Jul―09 COVID-19 comorbidities, associated pro-coagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity? Jameel Inal
121 [GO] 2020―Jul―09 Double-bright (CD56bright/CD16bright) NK cell adoptive immunotherapy for SARS-CoV-2 Lúcia Silla
122 [GO] 2020―Jul―08 Blood Component Use in Critical Care in Patients with COVID-19 Infection: A Single Centre Experience Andrew J Doyle, Anicee Danaee, Charlene I Furtado, Scott Miller, Tim Maggs, Susan E Robinson, Andrew Retter
123 [GO] 2020―Jul―08 CoVID-19 insights from transfusion medicine Willy A. Flegel
124 [GO] 2020―Jul―06 Effect of low or high doses of low molecular weight heparin on thrombin generation and other hemostasis parameters in COVID-19 critical patients Antonio Chistolini, Franco Ruberto, Francesco Alessandri, Cristina Santoro, Francesco Barone, Maria Cristina Puzzolo, et al. (+66)
125 [GO] 2020―Jul―04 COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges Alfonso Piciocchi, Monica Messina, Stefano Soddu, Edoardo La Sala, Francesca Paoloni, Giorgia Giuliani, et al. (+5)
126 [GO] 2020―Jul―04 Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: Methodological issues and clinical implications Anastasios Kollias, Konstantinos G Kyriakoulis, George S Stergiou, Konstantinos Syrigos
127 [GO] 2020―Jul―01 ABO Phenotype and Death in Critically Ill Patients with COVID-19 Rebecca Karp Leaf, Hanny Al-Samkari, Samantha K. Brenner, Shruti Gupta, David E. Leaf
128 [GO] 2020―Jul―01 Concerns about how to use established minimal residual disease (MRD) monitoring in the treatment of NPM1 -mutant AML following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemic Nadine Farah, Richard Burt, Amr R Ibrahim, Robert Baker, Panagiotis D Kottaridis
129 [GO] 2020―Jun―27 Convalescent plasma for persisting Covid-19 following therapeutic lymphocyte depletion: a report of rapid recovery E. Clark, P. Guilpain, L. Filip, N. Pansu, C. Le Bihan, G. Cartron, et al. (+6)
130 [GO] 2020―Jun―27 Ruxolitinib for tocilizumab-refractory severe COVID-19 infection Andrew J Innes, Lucy B Cook, Sasha Marks, Edward Bataillard, Christina Crossette-Thambiah, Gayathiri Sivasubramaniam, et al. (+2)
131 [GO] 2020―Jun―27 Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID-19 pneumonia J. Chopra, HJ. Hiew, A. Cumpstey, F. Cagampang, MW. Jenner, A. Dushianthan
132 [GO] 2020―Jun―25 Successful remission induction therapy with gilteritinib in a patient with de novo FLT3 -mutated acute myeloid leukaemia and severe COVID-19 Andrew J. Wilson, Ethan Troy-Barnes, Maryam Subhan, Fiona Clark, Rajeev Gupta, Adele K. Fielding, et al. (+8)
133 [GO] 2020―Jun―25 COVID-19 mortality in patients on anticoagulants and antiplatelet agents Helena Sivaloganathan, Eleni E Ladikou, Timothy Chevassut
134 [GO] 2020―Jun―25 Amelioration of COVID-19 related cytokine storm syndrome: Parallels to chimeric antigen receptor-T cell cytokine release syndrome Ryan L. Hoiland, Sophie Stukas, Jennifer Cooper, Sonny Thiara, Luke Y.C. Chen, Catherine M. Biggs, et al. (+6)
135 [GO] 2020―Jun―25 Combined IL-6 and JAK-STAT inhibition therapy in COVID-19 related sHLH, potential game changer Sophie Portsmore, Thien Ngoc Tran Nguyen, Emma Beacham, Pratap Neelakantan
136 [GO] 2020―Jun―19 Haematological Cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date Dima El-Sharkawi, Sunil Iyengar
137 [GO] 2020―Jun―17 Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19 Julien Maquet, Margaux Lafaurie, Agnès Sommet, Guillaume Moulis, Muriel Alvarez, Jacques Amar, et al. (+47)
138 [GO] 2020―Jun―15 Rapid screening of COVID-19 patients by White blood cells scattergrams, a study on 381 patients Jennifer Osman, Jérome Lambert, Marie Templé, Floriane Devaux, Rémy Favre, Claire Flaujac, et al. (+12)
139 [GO] 2020―Jun―12 C1-INH and the contact system in COVID-19 Timothy M Thomson, Emily Toscano, Ernesto Casis, Rosanna Paciucci
140 [GO] 2020―Jun―12 Haemophagocytosis in bone marrow aspirates in patients with COVID-19 Agathe Debliquis, Inès Harzallah, Joy Y. Mootien, Antoine Poidevin, Guylaine Labro, Amira Mejri, et al. (+3)
141 [GO] 2020―Jun―11 Secondary HLH is uncommon in severe COVID-19 Henry Wood, John Jones, Kit Hui, Tracey Mare, Tasneem Pirani, James Galloway, et al. (+5)
142 [GO] 2020―Jun―11 Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience Vallari Shah, Thinzar Ko Ko, Mark Zuckerman, Jennifer Vidler, Sobia Sharif, Varun Mehra, et al. (+19)
143 [GO] 2020―Jun―09 ITP flare with mild COVID-19 infection in pregnancy: A case report George Nesr, Catherine Garnett, Chris Bailey, Siamak Arami
144 [GO] 2020―Jun―09 Anti-A Isohemagglutinin titers and SARS-CoV2 neutralization: implications for children and convalescent plasma selection Daniele Focosi
145 [GO] 2020―Jun―04 Terminal complement inhibition dampens the inflammation during COVID-19 Austin G Kulasekararaj, Ioanna Lazana, Joanna Large, Kristina Posadas, Helen Eagleton, John Lord Villajin, et al. (+3)
146 [GO] 2020―Jun―04 Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus Tarryn Lee Carlsson, Benjamin Walton, Graham Collin
147 [GO] 2020―Jun―02 Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19 Joseph A. Hippensteel, Ellen L. Burnham, Sarah E. Jolley
148 [GO] 2020―Jun―02 Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in β-Thalassemias: The Nationwide Iranian Experience Mehran Karimi, Sezaneh Haghpanah, Azita Azarkeivan, Zohreh Zahedi, Tahereh Zarei, Maryam Akhavan Tavakoli, et al. (+3)
149 [GO] 2020―Jun―02 Re The source of elevated plasma D-dimer levels in COVID-19 infection Beverley J Hunt, Marcel Levi
150 [GO] 2020―Jun―01 A Case Series of MGUS and COVID-19 Jesus D. Gonzalez-Lugo, Lizamarie Bachier-Rodriguez, Mendel Goldfinger, Aditi Shastri, R. Alejandro Sica, Kira Gritsman, et al. (+7)
151 [GO] 2020―Jun―01 Interleukin-6 Blockade Treatment for COVID-19 associated Cytokine Release Syndrome in a Patient with Poorly Controlled Chronic Myeloid Leukaemia Amita Ranger, Ruby Haji, Richard Kaczmarski, Akila Danga
152 [GO] 2020―Jun―01 Challenges in the Management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, et al. (+8)
153 [GO] 2020―Jun―01 Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of severe COVID-19 patients Nadia Caccamo, Lucy C. Sullivan, Andrew G. Brooks, Francesco Dieli
154 [GO] 2020―Jun―01 Conquest of COVID-19. Publish it to Death? Robert Peter Gale
155 [GO] 2020―Jun―01 Persisting SARS-CoV-2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature Phil-Robin Tepasse, Wali Hafezi, Mathias Lutz, Joachim Kühn, Christian Wilms, Rainer Wiewrodt, et al. (+4)
156 [GO] 2020―May―29 Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience Alexandros Kanellopoulos, Maria Zahid Ahmed, Bhuvan Kishore, Richard Lovell, Claire Horgan, Paneesha Shankara, et al. (+12)
157 [GO] 2020―May―27 Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19) Emily Zagorski, Tushar Pawar, Shoja Rahimian, Daniel Forman
158 [GO] 2020―May―26 Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19) Wanxin Chen, Ziping Li, Bohan Yang, Ping Wang, Qiong Zhou, Zhiguo Zhang, et al. (+4)
159 [GO] 2020―May―26 COVID-19 and ABO blood group: another viewpoint Christiane Gérard, Gianni Maggipinto, Jean-Marc Minon
160 [GO] 2020―May―26 Haemoglobin Oxygen Affinity in Patients with Severe COVID-19 Infection Y Daniel, BJ Hunt, A Retter, K Henderson, S Wilson, CC Sharpe, MJ Shattock
161 [GO] 2020―May―26 Efficacy of therapeutic plasma exchange in severe COVID-19 patients Li Zhang, Hui Zhai, Shasha Ma, Jiasheng Chen, Yu Gao
162 [GO] 2020―May―26 Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? Francesca Angileri, Sébastien Légaré, Antonella Marino Gammazza, Everly Conway de Macario, Alberto J. L. Macario, Francesco Cappello
163 [GO] 2020―May―26 Clinical significance of blue-green neutrophil and monocyte cytoplasmic inclusions in SARS-CoV-2 positive critically ill patients Miguel D. Cantu, William S. Towne, Foxwell N. Emmons, Maria Mostyka, Alain Borczuk, Steven P. Salvatore, et al. (+4)
164 [GO] 2020―May―23 Managing Sickle Cell Patients With COVID-19 Infection: The Need to Pool Our Collective Experience Kamal Kant Sahu, Ahmad Daniyal Siddiqui, Jan Cerny
165 [GO] 2020―May―21 Molecular mechanisms for thrombosis risk in black people: a role in excess mortality from Covid-19 Roshan amasamy, Kate M Milne, Simon M Stoneham, Timothy JT Chevassut
166 [GO] 2020―May―21 Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy. Gordon Cook, A John Ashcroft, Guy Pratt, Rakesh Popat, Karthik Ramasamy, Martin Kaiser, et al. (+10)
167 [GO] 2020―May―21 IL-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement James W. Day, Thomas A. Fox, Richard Halsey, Ben Carpenter, Panagiotis D. Kottaridis
168 [GO] 2020―May―20 Protective Role of BTK Inhibitors in Patients with Chronic Lymphocytic Leukemia and COVID-19 Santiago Thibaud, Douglas Tremblay, Sheena Bhalla, Brittney Zimmerman, Keith Sigel, Janice Gabrilove
169 [GO] 2020―May―20 High Fluorescent Lymphocytes Are Increased in COVID-19 Patients Zhao Wang, Yu He, Huaqing Shu, Ping Wang, Hui Xing, Xiaoqian Zeng, Zhaoming Tang
170 [GO] 2020―May―19 Covid-19 and Myeloma: what are the implications for now and in the future? Ciara L Freeman, Joseph Mikhael
171 [GO] 2020―May―19 Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum Isabel Farmer, Jumoke Okikiolu, Matthew Steel, Chandima Wanniarachchi, Shona Littlewood, Sunil Gupta, et al. (+5)
172 [GO] 2020―May―18 Atypical lymphocytes in peripheral blood of patients with COVID-19 Samuel E. Weinberg, Amir Behdad, Peng Ji
173 [GO] 2020―May―18 Evans syndrome in a patient with COVID-19 Monica Li, Charles B. Nguyen, Zachary Yeung, Katherine Sanchez, Daniel Rosen, Sita Bushan
174 [GO] 2020―May―18 The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants Shi-Qin Jiang, Qiu-Fen Huang, Wei-Ming Xie, Chao Lv, Xiao-Qing Quan
175 [GO] 2020―May―18 Patients with Sickle cell disease and suspected COVID-19 in a pediatric ICU C Heilbronner, L Berteloot, P Tremolieres, L Dupic, L De Saint Blanquat, F Lesage, et al. (+9)
176 [GO] 2020―May―18 Temporal Changes in Immune Blood Cell Parameters in COVID-19 Infection and Recovery from Severe Infection Christina YC Yip, Eng Soo Yap, Sanjay De Mel, Winnie Z.Y. Teo, Chun-Tsu Lee, Sheryl Kan, et al. (+4)
177 [GO] 2020―May―18 First Covid-19 maternal mortality in the UK associated with thrombotic complications Irshad Ahmed, Ahamed Azhar, Nashwa Eltaweel, Bee K Tan
178 [GO] 2020―May―18 Dynamic relationship between D-dimer and COVID-19 severity Yong Li, Kun Zhao, Hongcheng Wei, Wensen Chen, Wei Wang, Ling Jia, et al. (+6)
179 [GO] 2020―May―18 Successful prevention and screening strategies for COVID-19: focused on patients with hematologic diseases Sung-Yeon Cho, Sung-Soo Park, Ji-Young Lee, Hee-Je Kim, Yoo-Jin Kim, Chang-Ki Min, et al. (+3)
180 [GO] 2020―May―18 Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients James A. Aries, Jeffrey K. Davies, Rebecca L. Auer, Simon L. Hallam, Silvia Montoto, Matthew Smith, et al. (+14)
181 [GO] 2020―May―18 More on “Association between ABO blood groups and risk of SARS-CoV-2 Pneumonia” Jamie M. O’Sullivan, Soracha Ward, Helen Fogarty, James S. O’Donnell
182 [GO] 2020―May―13 More on COVID-19 Coagulopathy in Caucasian patients Helen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Paul Browne, et al. (+9)
183 [GO] 2020―May―07 Survival study of hospitalized patients with concurrent Covid-19 and haematological malignancies Fernando Martín-Moro, Juan Marquet, Miguel Piris, Berta M Michael, Adolfo J Sáez, Magdalena Corona, et al. (+8)
184 [GO] 2020―May―07 COVID-19 in a patient with pre-existing acute lymphoblastic leukemia Yinlian Wu, Heng Lin, Qiang Xie, Qun Chen, Yanfang Huang, Yueyong Zhu, Lizhou Chen
185 [GO] 2020―May―07 Outcome of a patient with refractory Hodgkin’s Lymphoma on pembrolizumab, infected with SARS-CoV-2 Brendan O’Kelly, Padraig McGettrick, Daniel Angelov, Michael P Fay, Tara McGinty, Aoife G Cotter, et al. (+2)
186 [GO] 2020―May―07 Association between ABO blood groups and risk of SARS-CoV-2 pneumonia Juyi Li, Xiufang Wang, Jian Chen, Yi Cai, Aiping Deng, Ming Yang
187 [GO] 2020―May―06 Arterial thromboembolic complications in COVID-19 in low risk patients despite prophylaxis Daniel O. Griffin, Alexandra Jensen, Mushmoom Khan, Jessica Chin, Kelly Chin, Ryan Parnell, et al. (+2)
188 [GO] 2020―May―06 Autoimmune hemolytic anemia associated with Covid-19 infection Gregory Lazarian, Anne Quinquenel, Mathieu Bellal, Justine Siavellis, Caroline Jacquy, Daniel Re, et al. (+6)
189 [GO] 2020―May―06 Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic S. Pavord, J. Thachil, B. Hunt, M. Murphy, G. Lowe, M. Laffan, et al. (+5)
190 [GO] 2020―May―05 Concomitant hemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukemia Mathieu Baldacini, Raoul Pop, Laurent Sattler, Laurent Mauvieux, Karin Bilger, Justine Gantzer, et al. (+4)
191 [GO] 2020―May―05 Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia Chris Lopez, Jeremy Kim, Apurva Pandey, Ted Huang, Thomas G. DeLoughery
192 [GO] 2020―May―05 IL-6 blockade treatment for severe COVID-19 in two patients with multiple myeloma Aristeidis Chaidos, Alexia Katsarou, Chira Mustafa, Dragana Milojkovic, Anastasios Karadimitris
193 [GO] 2020―May―05 COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience Kayleigh A. McCloskey, John Meenan, Rhys Hall, Dimitris A. Tsitsikas
194 [GO] 2020―May―05 Severe COVID-19 infection and thrombotic microangiopathy: success doesn't come easily Eleni Gavriilaki, Robert Alan Brodsky
195 [GO] 2020―May―05 Assessing the Impact of Lockdown: Fresh Challenges for the Care of Haematology Patients in the COVID-19 Pandemic John Willan, Andrew John King, Faouzi Djebbari, Gareth D.H. Turner, Daniel J. Royston, Sue Pavord, et al. (+2)
196 [GO] 2020―May―05 Ph+ Acute Lymphoblastic Leukaemia in Italy During the Covid-19 Pandemic. A Campus ALL Study Robin Foà, Massimiliano Bonifacio, Sabina Chiaretti, Antonio Curti, Anna Candoni, Carmen Fava, et al. (+3)
197 [GO] 2020―May―05 Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease - has not received enough attention till date Brian Hanley, Candice A Roufosse, Michael Osborn, Kikkeri N Naresh
198 [GO] 2020―May―05 Thrombocytopenia as an initial manifestation of Covid-19; Case Series and Literature review Maria Zahid Ahmed, Muhammad Khakwani, Indrani Venkatadasari, Claire Horgan, Hannah Giles, Shailesh Jobanputra, et al. (+4)
199 [GO] 2020―May―05 Favourable outcome of Coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression Elena Sieni, Francesco Pegoraro, Tommaso Casini, Annalisa Tondo, Barbara Bortone, Maria Moriondo, et al. (+3)
200 [GO] 2020―May―05 SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies Matteo Molica, Carla Mazzone, Iole Cordone, Alessia Pasquale, Pasquale Niscola, Paolo de Fabritiis
201 [GO] 2020―Apr―30 Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19 Paul Vulliamy, Sabu Jacob, Ross A Davenport
202 [GO] 2020―Apr―24 COVID-19 Coagulopathy in Caucasian patients Helen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Paul Browne, et al. (+9)
203 [GO] 2020―Apr―24 Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic Noémi BA Roy, Paul Telfer, Perla Eleftheriou, Josu de la Fuente, Emma Drasar, Farrukh Shah, et al. (+11)
204 [GO] 2020―Apr―21 COVID-19 Infection in Patients with Sickle Cell Disease Faiz A. Hussain, Franklin U. Njoku, Santosh L. Saraf, Robert E. Molokie, Victor R. Gordeuk, Jin Han
205 [GO] 2020―Apr―20 SARS-CoV-2: A new aetiology for atypical lymphocytes Delphine Gérard, Sylvain Henry, Benoît Thomas
206 [GO] 2020―Apr―18 Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID-19): a Meta-Analysis Mi Xiong, Xue Liang, You-Dong Wei
207 [GO] 2020―Apr―18 Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action Anastasios Kollias, Konstantinos G Kyriakoulis, Evangelos Dimakakos, Garyphallia Poulakou, George S. Stergiou, Konstantinos Syrigos
208 [GO] 2020―Apr―16 Reactive lymphocytes in patients with Covid-19 Vanessa Cui Lian Chong, Eric Kian Guan Lim, Eugene Bingwen Fan, Stephrene Seok Wei Chan, Kiat Hoe Ong, Ponnudurai Kuperan
209 [GO] 2020―Apr―16 How we deal with the COVID-19 epidemic in an Italian pediatric onco-hematology clinic located in a region at high density of cases Laura Sainati, Alessandra Biffi
210 [GO] 2020―Apr―16 Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients Suxin Wan, Qingjie Yi, Shibing Fan, Jinglong Lv, Xianxiang Zhang, Lian Guo, et al. (+9)
211 [GO] 2020―Apr―16 Management of COVID-19 Related Paediatric Blood Samples in a Clinical Haematology Laboratory Joyce Ching Mei Lam, Grace Benjamin Moshi, Soh Hong Ang, Hui Ming Chew, Qing Hui Ng, Andrew Madjukie, Logeswary M
212 [GO] 2020―Apr―14 The proportion of patients with thrombocytopenia in three human-susceptible coronavirus infections: a systematic review and meta-analysis Meng Zhou, Jiaqian Qi, Xueqian Li, Ziyan Zhang, Yifang Yao, Depei Wu, Yue Han
213 [GO] 2020―Apr―13 Editorial - COVID-19 John Barret
214 [GO] 2020―Mar―17 How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat? Bhagirathbhai Dholaria, Bipin N. Savani
215 [GO] 2020―Mar―16 Care of haematology patients in a COVID-19 epidemic John Willan, Andrew J. King, Sandy Hayes, Graham P. Collins, Andrew Peniket

215 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec